[Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology] [0.03%]
[哥伦比亚风湿病学会关于萨斯冠状病毒新冠肺炎感染背景下成人患者风湿性疾病管理的推荐意见]
Lina María Saldarriaga Rivera,Daniel Fernández Ávila,Wilson Bautista Molano et al.
Lina María Saldarriaga Rivera et al.
Objective: To produce recommendations for patients with rheumatological diseases receiving immunomodulatory and immunosuppressive therapies (conventional drugs, biologicals, and small molecules) during the COVID-19 pandem...
[Biological therapy as an alternative treatment for cytokine release syndrome in patients with COVID-19] [0.03%]
[生物疗法作为新冠肺炎细胞因子风暴的替代治疗]
Urbano Solis Cartas
Urbano Solis Cartas
[Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion] [0.03%]
新冠肺炎疫情期间风湿病患者用药管理推荐意见专家讨论稿
Josué-Guillermo López,Jhyld-Carolaind Camacho-Barbosa,Oscar-Jair Felipe-Díaz et al.
Josué-Guillermo López et al.
Coronavirus 2019 (COVID-19) is an unexpected pandemic that has caused a state of emergency, as well as generating drastic changes in clinical care protocols. Some drugs commonly used in rheumatoid arthritis, systemic lupus erythematosus, an...
Interstitial Pneumonia with Autoimmune Features: Aiming to Define, Refine, and Treat [0.03%]
具有自身免疫特征的间质性肺炎：定义、精炼和治疗
Elena K Joerns,Jeffrey A Sparks
Elena K Joerns
Interstitial pneumonia with autoimmune features (IPAF) was defined for research purposes as interstitial lung disease (ILD) associated with features of autoimmunity without diagnosed rheumatic disease. Since publication of the IPAF criteria...
Screening, diagnosis, and monitoring of interstitial lung disease in autoimmune rheumatic diseases: A narrative review [0.03%]
自身免疫性风湿病间质性肺疾病的筛查、诊断和监测：叙述性综述
Samuel D Good,Jeffrey A Sparks,Elizabeth R Volkmann
Samuel D Good
Interstitial lung disease (ILD) is a common and serious manifestation of autoimmune rheumatic diseases. While the prevalence of ILD differs among the individual autoimmune rheumatic diseases, ILD remains an important cause of morbidity and ...